Same industry

ACAD against four drug peers, a year at 100

80100120140160Feb ’26MayAugNov ’26LLY+27.5%JNJ+31.0%ABBV+20.0%MRK+35.8%ACAD−25.3%

ACAD −25.3%. Merck +35.8%, Johnson & Johnson +31.0%, Eli Lilly +27.5%, AbbVie +20.0%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in ACAD’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

ACAD: stories, the record and filings →